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Histamine H1 and H2 receptors are essential transducers 
of the integrative exercise training response in humans
Thibaux Van der Stede1,2, Laura Blancquaert1, Flore Stassen1, Inge Everaert1, Ruud Van Thienen1, 
Chris Vervaet3, Lasse Gliemann2, Ylva Hellsten2, Wim Derave1*
Exercise training is a powerful strategy to prevent and combat cardiovascular and metabolic diseases, although 
the integrative nature of the training-induced adaptations is not completely understood. We show that chronic 
blockade of histamine H1/H2 receptors led to marked impairments of microvascular and mitochondrial adaptations 
to interval training in humans. Consequently, functional adaptations in exercise capacity, whole-body glycemic 
control, and vascular function were blunted. Furthermore, the sustained elevation of muscle perfusion after acute 
interval exercise was severely reduced when H1/H2 receptors were pharmaceutically blocked. Our work suggests 
that histamine H1/H2 receptors are important transducers of the integrative exercise training response in humans, 
potentially related to regulation of optimal post-exercise muscle perfusion. These findings add to our understand-
ing of how skeletal muscle and the cardiovascular system adapt to exercise training, knowledge that will help us 
further unravel and develop the exercise-is-medicine concept.
INTRODUCTION
Aerobic exercise training is a potent preventive and therapeutic 
strategy for cardiovascular, metabolic, and other chronic diseases (1). 
Molecular mechanisms underlying these exercise-induced health- 
promoting effects may range from autocrine/paracrine signaling 
within skeletal muscle to whole-body organ cross-talk (2). These 
events induce adaptations within skeletal muscle such as increased 
capillarization and mitochondrial capacity, leading to improved 
metabolic health. Precisely how the beneficial effects of exercise 
training on skeletal muscle and the cardiovascular system are medi-
ated at a molecular level remains undisclosed. However, a complete 
understanding of the mechanisms underlying the health-related 
benefits of exercise training is essential to further unravel its poten-
tial clinical impact (3) and develop novel therapeutic and exercise 
modality strategies (4).
In recent years, histamine has emerged as a potentially important 
mediator of acute and chronic exercise responses (5). The primordial 
basis of the histamine system dates back from before the origin of 
multicellular organisms, with a highly conserved genetic sequence 
of the histamine-forming enzyme histidine decarboxylase, which 
also is present in humans (6). Histamine exerts its biological effects 
via four heterotrimeric guanine nucleotide-binding protein–coupled 
histamine receptors, H1 to H4, of which H1 and H2 receptors are most 
frequently studied in relation to exercise (5) and are known to be 
widely expressed within skeletal muscle (7).
Although the research interest in histamine has mainly been di-
rected to allergic reactions, inflammation, and gastric acid secretion, 
as early as in 1935, it was shown that muscle contractions induce an 
increase in venous histamine concentrations in dogs (8). More re-
cently, McCord and Halliwill (9) documented the role of H1/H2 re-
ceptors in mediating sustained post-exercise hyperemia in humans. 
Some studies further addressed the effect of H1/H2 blockade on the 
acute moderate-intensity exercise response, although the topic re-
mains largely understudied (10–13).
It is currently unknown whether and how the histamine system 
is relevant for exercise training adaptations. In the current study, we 
first confirmed that muscle perfusion after acute interval exercise 
was severely blunted with pharmaceutical H1/H2 blockade. Next, 
we evaluated the role of histamine signaling for exercise training–
induced adaptations by chronic blockade of H1/H2 receptors during 
a 6-week interval training program in healthy males. We found that 
the chronic blockade severely impaired multiple clinically relevant 
adaptations to exercise training, i.e., exercise capacity, glycemic con-
trol, and vascular function. Our human histamine blockade strategy 
provides important insights into the role of H1/H2 signaling in the 
adaptive response to exercise training and emphasizes translational 
and therapeutic potential of the histamine pathway.
RESULTS
Post-exercise muscle perfusion is dependent on H1/H2 
receptor signaling
To study the effects of H1/H2 blockade on the hemodynamic re-
sponse during and after interval cycling exercise, healthy adults per-
formed a single exercise session with either placebo (control) or H1/H2 
antagonist intake (blockade) on separate days in a randomized 
and single-blinded design (Fig. 1A and table S1). At rest, acute 
ingestion of H1/H2 blockers did not alter heart rate, brachial blood 
pressure, femoral arterial blood flow, or femoral arterial diameter 
(table S1). The heart rate response during exercise was not different 
between the placebo and blockade trial (fig. S1A). Muscle perfusion 
was increased approximately threefold 15 min after exercise and was 
still ~50% above baseline after 2 hours of passive recovery in the 
placebo condition. However, the total post-exercise muscle perfusion, 
expressed as iAUC (incremental area under the curve), was signifi-
cantly reduced with H1/H2 blockade by ~35% (Fig. 1B and fig. S1B). 
The brachial arterial blood pressure showed a modest increase during 
the 2-hour post-exercise period (main effect time) and was, in gen-
eral, higher after placebo intake (main effect condition) (Fig. 1C). 
The increase in post-exercise vascular conductance, an important 
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measure of vascular tone, was consequently blunted with H1/H2 
blockade (Fig. 1D). Similar to during exercise, post-exercise heart rate 
recovery was unaffected by H1/H2 blockade (fig. S1C). Collectively, 
these data demonstrate that histamine H1/H2 receptors are essential 
for the regulation of sustained elevation of muscle perfusion follow-
ing interval exercise.
Exercise capacity and mitochondrial function are regulated 
by H1/H2 receptors
In a chronic 6-week training study, participants were divided in placebo 
(CON) and H1/H2 blockade (BLOCK) groups in a double-blinded, 
randomized controlled trial design, matched for similar baseline 
group characteristics (table S2). Both groups performed the same 
exercise training program (Fig. 2A and fig. S2A), which elicited 
similar relative training intensities (fig. S2, B and C) and adherence 
(table S2). Resting heart rate tended to decrease in CON but not in 
BLOCK (table S2). Since a high aerobic exercise capacity is an essen-
tial protective measure against metabolic dysfunction, we assessed 
training-induced changes in exercise capacity with an incremental 
cycling test. Maximal oxygen uptake increased moderately with train-
ing (main effect of training), with no statistical differences between 
CON (+3.9%) and BLOCK (+0.3%) (Fig. 2B and fig. S3A). Func-
tionally, peak power output increased in both groups, with the in-
crease being significantly greater in CON than in BLOCK (+12% 
versus +7%; Fig. 2B and fig. S3B). Similar to the functional maximal 
data, both the gas exchange threshold (GET) and respiratory com-
pensation point (RCP) increased substantially with training in 
both groups (fig. S3, C and D), although the increase in CON (+22 
and +19%) was significantly greater than in BLOCK (+11 and +6%) 
(Fig. 2B). As second functional outcome, we evaluated the capacity 
to recover after maximal exercise by a time to exhaustion test at a 
fixed work rate, performed after a 10-min recovery upon cessation 
of the incremental exercise test. The time to exhaustion improved 
with training in CON (+81%) and in BLOCK (+31%) (fig. S3E). Ad-
aptations at a submaximal level were further studied via a steady-
state exercise test at a constant submaximal power output. Average 
heart rate during this test decreased in CON (−9%) but not in BLOCK 
(Fig. 2C). The total energy required to perform this exercise bout, 
reflecting exercise efficiency, was calculated on the basis of the gas 
exchange data and was also decreased in CON but not in BLOCK 
(Fig. 2C). Capillary lactate levels at the end of the exercise bout de-
creased with training, independent of group (fig. S3F).
As several training-induced adaptations in exercise capacity were 
impaired with H1/H2 blockade, we determined the potential link with 
mitochondrial function. Maximal citrate synthase (CS) activity in 
skeletal muscle biopsies as marker for mitochondrial capacity in-
creased in both groups, with the increase being significantly greater 
in CON (+33%) compared to BLOCK (+14%) (Fig. 2D). The mito-
chondrial antioxidant superoxide dismutase 2 (SOD2) protein content 
was also markedly increased in CON (+56%) but not in BLOCK (+18%) 
(Fig. 2E). On the basis of the finding that antioxidant adaptations 
were blunted in BLOCK, the p67phox subunit of the membrane-bound 
superoxide-producing NADPH (reduced form of nicotinamide ade-
nine dinucleotide phosphate) oxidase (NOX) protein content was 
determined. NOX p67phox content increased similarly with training in 
both groups (+61% versus +63% in CON versus BLOCK) (Fig. 2E). 
These data indicate an essential role of H1/H2 receptors in regulating 
improvements in exercise performance related to mitochondrial 
capacity and antioxidant protein expression.
Improvement in whole-body glucose homeostasis is blunted 
by H1/H2 blockade
Exercise training is known to improve insulin action, glucose homeo-
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Fig. 1. Acute post-exercise hemodynamics. (A) Experimental procedures of the acute exercise study (n = 8). GET, gas exchange threshold; RCP, respiratory compensation point. 
(B) Total muscle perfusion during the 2-hour post-exercise period, expressed as iAUC. (C) Arterial blood pressure and (D) vascular conductance at baseline and during the 
2-hour post-exercise period. Data are presented as means + individual data points (B) or means ± SD (C and D). *P < 0.05 for CON (placebo treated) versus BLOCK (H1/H2 
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control was assessed before and after the intensive exercise training 
program by an oral glucose tolerance test (OGTT) and muscle biop-
sies in resting conditions. Exercise training decreased fasted blood 
glucose levels in CON only (table S2). Fasted blood levels of insulin, 
triglycerides, and cholesterol were unaffected by training (table S2). 
The total glucose and insulin levels during the OGTT, expressed as 
AUC, decreased substantially in CON (−11 and −30%) but not in 
BLOCK (+1 and −3%) (Fig. 3A). Glucose tolerance, expressed as the 
Matsuda index for whole-body insulin sensitivity, was accordingly 
significantly improved with training in CON (+26%), but this effect 
was completely abolished in BLOCK (+1%) (Fig. 3B). Muscle total 
GLUT4 protein content, the primary insulin-sensitive glucose trans-
porter in skeletal muscle, increased similarly with training in both 
groups (+17% versus +16% in CON versus BLOCK) (Fig. 3C).
Additional metabolic effects of H1/H2 blockade in muscle were 
explored by assessing metabolic enzymes related to energy delivery. 
Hydroxyacyl–coenzyme A dehydrogenase (HAD) activity, function-
ally active in fatty acid oxidation, increased with training, independent 
of group (+19% versus +11% in CON versus BLOCK) (Fig. 3D). 
The glycolytic rate-limiting enzyme phosphofructokinase (PFK) 
increased with training in CON with 13% and was unchanged in 
BLOCK (Fig. 3D). Hexokinase (HK) and lactate dehydrogenase (LDH) 
SOD2 NOX p67
Interaction: P = 0.023
P < 0.001 P = 0.088
Interaction: P = 0.728
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Fig. 2. Training-induced changes in exercise capacity and mitochondrial function. (A) Schematic overview of experimental procedures of the chronic training study 
(CON = 9 and BLOCK = 9). (B) Changes (in %) from pre-training in exercise capacity outcomes derived from an incremental cycling test. (C) Changes (in %) from pre-training 
in submaximal exercise performance (average heart rate and total energy expenditure). (D) Effect of training on muscle CS activity. (E) Effect of training on the muscle 
mitochondrial antioxidant SOD2 and superoxide anion–producing NOX, including representative Western blots. Data are presented as individual data points, accompa-
nied by horizontal lines (B and C) or bars (D and E) as means. *P < 0.05 versus baseline for respective group and #P < 0.05 for main effect of time. Data were analyzed using 
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activity were both unaffected by training (Fig. 3D). These effects of 
the interplay between exercise training and H1/H2 blockade on en-
zymes related to energy delivery did not affect substrate oxidation 
during submaximal cycling, although carbohydrate oxidation mod-
erately decreased with training (Fig. 3E). In conclusion, our results 
demonstrate that exercise training induced H1/H2 receptor–dependent 
metabolic adaptations related to whole-body insulin action and glyco-
lytic energy delivery pathways.
Blunted training-induced improvement in NO-dependent 
vascular function and muscle capillarization with  
H1/H2 blockade
As regular exercise training is a cornerstone strategy for improving 
cardiovascular health markers, we measured training-induced changes 
in these outcomes. Resting blood pressure did not change with train-
ing (table S2). Leg vascular function was assessed without H1/H2 
antagonist intake before and after the training intervention using the 
single passive leg movement (sPLM) technique (15). The blood flow 
response upon passive movement was increased in CON but not in 
BLOCK. More specifically, the total hyperemic response (iAUC), 
indicative of vascular function, was increased in CON (+37%) but 
not in BLOCK (−14%) (Fig. 4, A and B). The maximal blood flow 
increase from baseline and the absolute peak blood flow during 
sPLM were also increased in CON only (+26 and +17%; table S2). 
Muscle capillarization, i.e., capillary-fiber ratio and capillary density, 
also increased with training in CON (+17 and +16%) but not in 
BLOCK (+5 and −1%) (Fig. 4C). Muscle fiber area was unaffected 
by exercise training and H1/H2 blockade (table S2). To unravel the 
mechanistic cause for this blunted increase in NO-dependent vascu-
lar function and muscle capillarization, we determined the expres-
sion of related proteins. Muscle vascular endothelial growth factor 
(VEGF) content increased with training, independent of group 
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Fig. 3. Metabolic outcomes in response to exercise training. (A) Response curves and changes of AUC of glucose and insulin during the OGTT pre- and post-training. 
(B) Effect of training on whole-body insulin sensitivity, assessed with the Matsuda index derived from OGTT data. (C) Expression of muscle total GLUT4 content before and 
after the training intervention, including representative Western blots. (D) Changes (in %) from pre-training in activity of enzymes related to energy delivery pathways. 
(E) Changes (in kcal) from pre-training in carbohydrate (CHO) and fat oxidation during submaximal cycling. CON = 9 and BLOCK = 9. Data in (A) are presented as means ± SD 
(glucose) or SEM (insulin, for visual reasons). Data in (B to E) are illustrated as individual data points with mean as bar (B and C) or horizontal line (D and E). *P < 0.05 versus 
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(+29% versus +23% in CON versus BLOCK; Fig. 4D). Expression of 
endothelial nitric oxide synthase (eNOS) increased 17% in CON but 
was unchanged in BLOCK (Fig. 4E). Cyclooxygenase 1 (COX1) increased 
similarly in both groups (+38 and +23% in CON and BLOCK), whereas 
prostacyclin synthase  (PTGIS) and VEGF receptor 2 (VEGFR-2) were 
unaffected by training and group (Fig. 4E). In summary, chronic 
H1/H2 blockade blunted the training-induced improvement in leg 
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Fig. 4. Changes in vascular function and capillarization with exercise training. (A and B) Left: Blood flow traces during sPLM before and after training in CON (A) and 
BLOCK (B). The gray zone denotes baseline blood flow before initiation of passive movement. Right: iAUC of blood flow response before and after training in CON (A) and 
BLOCK (B). (C) Training-induced changes in capillary-fiber ratio (left) and capillary density (middle), accompanied by representative micrographs (right). (D) Effect of 
training on VEGF protein content. (E) Training-induced changes (in %) in protein content of vascular-related proteins: eNOS, COX1, PTGIS, and VEGFR-2, including repre-
sentative Western blots. n = 9 per group, except for COX1 (n = 8 because of technical difficulties). (A) and (B) (left) are means ± SD. All other panels are individual data points 
with mean as bar (A to D) or horizontal line (E). *P < 0.05 versus baseline for respective group and #P < 0.05 for main effect of time. Data were analyzed using linear mixed 
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H1/H2 receptor–dependent adaptations to interval training 
are highly interrelated
As chronic blockade of H1/H2 receptors blunted several different 
training-induced adaptations, we explored the interrelationship be-
tween the various functional and mechanistic outcomes at baseline, 
as well as their training-induced changes (Fig. 5, A and B). Training- 
induced changes in markers for maximal exercise capacity, i.e., 
VO2max and peak power output, were related to each other (fig. S4A) 
and to the decrease in submaximal exercise heart rate (fig. S4B). The 
changes in maximal exercise capacity were not related to changes in 
submaximal ventilatory thresholds GET and RCP (Fig. 5B). On the 
other hand, the increase in maximal exercise capacity was related to 
changes in vascular function, i.e., iAUC during sPLM (fig. S4C) and 
the Matsuda index for whole-body insulin sensitivity (fig. S4D). 
Furthermore, changes in CS activity were strongly related to all 
markers of vascular function (Fig. 5B and fig. S4E). The regulatory 
role of the microvasculature in metabolic control was further sup-
ported by the correlation between changes in capillary-fiber ratio 
and changes in whole-body insulin sensitivity (fig. S4F). These inter-
relationships indicate the integrative nature of whole-body adapta-
tions to interval exercise training and the regulatory role of H1/H2 
receptor signaling herein.
DISCUSSION
Exercise training induces health-promoting adaptations to multiple 
organ systems, orchestrated by an interplay between various exer-
cise factors and signaling events (2). In the present study, we show 
that histamine H1/H2 signaling is an essential transducer of the 
adaptive exercise training response with broad clinical relevance: 
aerobic capacity, glycemic control, and vascular function. These 
detrimental effects of H1/H2 blockade on functional outcomes were 
caused by impaired adaptations in key regulatory proteins, illustrating 
the integrative role of H1/H2 receptors in mediating exercise responses. 
One potential functional cause of the blunted training adaptations with 
histamine receptor blockade is a substantially reduced post-exercise 
muscle perfusion, as also observed in the current study. A summary 
of our findings is illustrated in Fig. 6.
In a chronic training study with H1/H2 blockade, we first observed 
marked reductions in training-induced effects on aerobic and mito-
chondrial capacity (Fig. 2 and fig. S3). Maximal exercise performance, 
i.e., VO2max, peak power output, and time to exhaustion test, was 
only moderately affected, but aspects related to submaximal perfor-
mance, i.e., ventilatory thresholds and submaximal heart rate and 
exercise efficiency, were more severely impaired. These data suggest 
that H1/H2 receptors are primarily relevant for peripheral, rather 
than central, adaptations in aerobic capacity. This is in accordance 
with the rather limited increase in VO2max, which was not statisti-
cally different between groups, as VO2max is primarily centrally reg-
ulated by the maximal capacity for O2 delivery, which is largely 
dependent on cardiac output (16). Peripheral adaptations such as 
increased muscle capillarization and mitochondrial capacity, how-
ever, occurred only in the placebo but not in the H1/H2 antagonist 
group, indicating a potential increase in O2 extraction during exercise, 
thereby affecting submaximal performance outcomes (17). This dis-
crepancy between maximal and submaximal adaptations is also under-
pinned by the absence of a correlation between training-induced 
changes in maximal performance and submaximal ventilatory thresh-
olds (Fig. 5B). Another peripheral adaptation that was negatively 
affected by histamine antagonism and could have contributed to the 
reduced effects of training on exercise performance was that of PFK, 
a rate-limiting enzyme in glycolysis. Future research will need to 
explore the exact role of H1/H2 receptors in the regulation of mito-
chondrial function and glycolytic energy production.
An additional important finding in our study was that training- 
induced adaptations related to glycemic control were impaired with 
H1/H2 blockade (Fig.  3). More specifically, whole-body insulin 
sensitivity did not increase in the experimental group treated with 
H1/H2 antagonists, whereas a substantial improvement was noted in 
placebo-treated participants. GLUT4 protein content, the primary 
glucose transporter in skeletal muscle (18), was similarly increased 
















































































































































































































Fig. 5. Training-induced changes via H1/H2 receptors are interrelated. (A) Correlation matrix for different outcomes at baseline (before training). (B) Correlation matrix 
for training-induced changes in all assessed outcomes. Presence of a circle within cell denotes a significant (P < 0.05) correlation between two variables, whereas the 
strength of the correlation (r value) is illustrated by size of the filling (e.g., half-filled circle depicts r value of 0.5). n = 18. Blue, positive correlation; red, negative correlation. 
Data were analyzed with Pearson correlation coefficients. CapFib, capillary-fiber ratio; Pmax, peak power output during incremental test; CD, capillary density; AUC_PLM, 
iAUC during sPLM; Peak_PLM, peak blood flow during sPLM; Delta_PLM, difference between peak and baseline blood flow during sPLM; HR_submax, average heart rate 
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are not mediated by H1/H2 receptors and up-regulation of total 
GLUT4 expression per se is not sufficient to induce improvements 
in whole-body insulin action. However, increased skeletal muscle 
capillarization was observed only in the placebo-treated group. 
Skeletal muscle capillarization is associated with muscle insulin sen-
sitivity (19, 20), and thus, the lack of increase in capillarization in 
the H1/H2 blockade group could, in part, explain the observed effects 
of a blunted increase in whole-body insulin action. This is in agree-
ment with the observed relationship between training-induced changes 
in capillary-fiber ratio and whole-body insulin sensitivity (fig. S4F). 
Similarly, the impaired up-regulation of eNOS content with H1/H2 
blockade could also be related, as insulin-stimulated NO production 
is important for optimal glucose uptake via regulation of muscle 
perfusion (21, 22). Last, disproportionate mitochondrial reactive 
oxygen species (ROS) production has been related to insulin resis-
tance (23, 24), implying that the observed impaired up-regulation 
of SOD2 protein content could have negatively altered mitochondrial 
redox status and thus affected adaptations in whole-body insulin 
action. In summary, our data suggest that H1/H2-dependent signal-
ing is involved in the exercise training–induced improvement of 
whole-body glycemic control. Whether this histaminergic effect is 
secondary to the observed blunting of angiogenesis and increase 
in abundance of related proteins or whether there also is a direct 
role in the up-regulation of the insulin signaling cascade is subject 
to further research.
A third functional outcome was that NO-dependent vascular 
endothelial function, as determined by the flow response to passive 
lower leg movement, was improved by exercise training in the 
placebo but not in the H1/H2 receptor antagonist group (Fig. 4). 
Endothelial function is overall highly dependent on NO bioavail-
ability (25), where the bioavailability, in turn, is determined by the 
balance between NO production and NO scavenging by ROS. Exer-
cise training increased the expression of eNOS and the mitochon-
drial antioxidant SOD2 in the control group but not in the H1/H2 
blockade group, whereas the expression of the p67phox subunit of 
NOX, a primary source of ROS, increased similarly in both groups. 
These findings indicate that the training-induced increase in NO 
bioavailability is blunted when H1/H2 receptors are chronically 
blocked, consequently leading to impaired adaptations in NO- 
dependent vascular function.
The histamine H1/H2-mediated training adaptations could be 
related, in part, to two distinct mechanisms. First, the acute exercise 
response in the muscle transcriptome related to vascular function, 
metabolism, inflammation, and other cellular functions is highly 
dependent on H1/H2 receptor signaling (12). These findings suggest 
that chronic blockade of H1/H2 receptors could negatively affect the 
cumulative training response, as observed in the current study. 
Second, sustained post-exercise muscle perfusion could be a key 
element for optimal muscle recovery (26) and subsequent training 
adaptations, as also suggested via post-exercise muscle cooling (27) 
and heating (28) strategies and blood flow restriction training (29). 
Although blood flow restriction training reduces muscle perfusion 
during exercise, it substantially enhances the perfusion after exercise 
(29). In our study, H1/H2 blockade induced marked reductions in 
muscle perfusion after interval cycling exercise (Fig. 1 and fig. S1), 
an effect likely present after each exercise session during the training 
program. One potential mechanism by which reduced muscle per-
fusion could impair chronic muscle adaptations is via shear stress, 
Fig. 6. Hypothesized working mechanism of H1/H2-dependent regulation of training adaptations. Left: Histamine H1/H2 receptors are mainly located on endothelial 
(H1) and vascular smooth muscle (H2) cells within skeletal muscle. Both receptors are activated during and following interval exercise, likely via an exercise-induced in-
crease in circulating histamine concentrations. Middle: After acute interval exercise, activation of H1/H2 receptors is essential to regulate the sustained elevation of muscle 
perfusion. With chronic interval training, H1/H2 receptor signaling during and following exercise mediates peripheral muscle adaptations related to mitochondria (CS 
activity and antioxidant protein expression), microvasculature (muscle capillarization and eNOS content), and glycolytic energy delivery (PFK activity). Right: These H1/H2- 
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the elevated blood flow in the capillary network during and after 
exercise. The H1/H2-dependent elevation in post-exercise blood flow 
and, thus, shear stress possibly mediated the up-regulation of muscle 
capillarization, as shear stress has been shown to be important for 
capillary growth (30) by leading to higher expression of angiogenic 
proteins in endothelial cells (31) and consequent splitting angiogenesis 
(32, 33). Furthermore, the blunted improvement in NO- dependent 
vascular function with H1/H2 blockade could be related to shear stress, as 
exercise training stimulates eNOS via shear stress–induced eNOSSer1177 
phosphorylation (34). Other consequences of a reduced muscle per-
fusion that could have contributed to the impaired adaptations are 
a reduced delivery of substrates, metabolites, and cytokines, but the 
exact mechanisms should be addressed in future research.
The finding that inhibiting one single piece in the exercise re-
sponse puzzle leads to blunted improvements in a broad range of 
molecular and functional systems is notable and contradicts the 
proposed integrated and redundant regulation of exercise adapta-
tions (35, 36). This indicates a role of H1/H2 receptors as essential 
molecular transducers or master regulators of exercise responses. It 
is unclear, however, whether chronic H1/H2 blockade induces a com-
plete inhibition of several key adaptations or rather unfavorably shifts 
the dose-response exercise curve so that a greater training stimulus 
is required for a similar response. A dose-response shift would im-
ply that other mechanisms would compensate for the lack of hista-
mine signaling, potentially of more importance if the physiological 
systems are more profoundly stimulated (e.g., longer training dura-
tion). Furthermore, the current intervention consisted of over-the-
counter antihistamine drugs. It is of pharmaceutical relevance that 
combined administration of exercise training and common medi-
cation negatively interact and lead to marked impairment of health- 
promoting adaptations. Other examples of adverse exercise-drug 
interactions have been reported in recent years, for example, met-
formin (37), resveratrol (38), and 2 agonists (39), illustrating the 
huge importance of this emerging research field.
In summary, we found that exercise-induced H1/H2 receptor 
signaling is essential for the integrative beneficial effects of exercise 
training on exercise capacity, metabolic control, and vascular func-
tion. This is likely related to an impaired post-exercise muscle per-
fusion and/or transcriptomic response with consequent blunted 
adaptations in the muscle microvasculature and mitochondrial con-
tent and antioxidant function (Fig. 6). Future studies should focus 
to further unravel the mechanisms underlying the H1/H2-dependent 
whole-body adaptations and on how the histamine system is affected 
by chronic diseases. Our data combined with these future endeavors 
will enable us to discover and develop previously unidentified drug 
targets and optimize exercise and pharmaceutical prescriptions.
MATERIALS AND METHODS
More details of participants, experimental procedures, and analytical 
techniques can be found in Supplementary Materials and Methods. 
The study conforms with the 2013 standards set by the Declaration 
of Helsinki, was approved by the Ethical Committee of Ghent Uni-
versity Hospital, Belgium (2018/1007 and 2019/1246), and is regis-
tered in ClinicalTrials.gov (NCT04450134).
Participants
After medical screening and written informed consent, 8 and 20 healthy 
adults participated in the acute and chronic study, respectively. For 
the chronic study, participants were randomly assigned to the placebo- 
(CON) or H1/H2 blockade–treated (BLOCK) group. One participant 
per group dropped out during the study period. More details are in 
the Supplementary Materials.
Acute exercise study design
In a crossover, single-blind (researcher), randomized study design, 
participants first attended an initial screening visit to determine ex-
ercise intensity for subsequent experimental days. The two test days 
were randomized between placebo and H1/H2 blockade and con-
sisted of a single identical exercise session with pre- and post-exercise 
measurements (Fig. 1A). Measurements included heart rate during 
exercise and femoral arterial blood flow, brachial blood pressure, 
and heart rate before and after exercise. More details are in the 
Supplementary Materials.
Chronic training study design
In a double-blind, placebo-controlled, and randomized study, partic-
ipants performed a 6-week training intervention (Fig. 2A). Outcomes 
related to exercise capacity (maximal and submaximal exercise test-
ing and muscle biopsies), metabolic health (OGTT and muscle 
biopsies), and NO-dependent vascular function (sPLM and muscle 
biopsies) were assessed before and after the training intervention. 
Exercise training consisted of three weekly sessions of cycling inter-
val training (fig. S2A). Furthermore, an intermediate incremental 
cycling test was performed after 3 weeks of training to adjust exer-
cise intensities during the training sessions. More details are in the 
Supplementary Materials.
H1/H2 blockade
A double blockade of H1/H2 receptors was performed in all inter-
ventions by administration of 540 mg of fexofenadine (H1) and 
300 mg of ranitidine or 40 mg of famotidine (H2; see the Supple-
mentary Materials for details). Capsule intake was 1 hour before each 
training session, and group allocation was blinded for participants 
and researchers. Capsule intake compliance was reported as 100%. 
More details are in the Supplementary Materials.
Maximal incremental cycling test
After a 6-min warm-up at 75 W, the work rate increased continuously 
by 25 W every minute until volitional exhaustion despite strong 
verbal encouragement. After a 10-min passive rest period, a time to 
exhaustion test was performed by cycling at 90% of the peak power 
output during the incremental cycling test until exhaustion. The 
work rate for this time to exhaustion test was kept constant for the 
intermediate and post-training testing. Whole-body oxygen uptake 
was measured breath by breath with a metabolic system (MetaLyzer 
3B; Cortex Biophysik GmbH, Leipzig, Germany), and heart rate was 
measured continuously (H7; Polar, Kempele, Finland). Details con-
cerning determination of peak oxygen uptake, power output, and 
heart rate as well as ventilatory thresholds can be found in the 
Supplementary Materials.
Blood pressure and heart rate
Blood pressure and heart rate were measured in the left arm using 
an automated sphygmomanometer (M3 Comfort; Omron Healthcare, 
Hoofddorp, The Netherlands). In the acute study, this was measured 
in triplicate at each time point, whereas an average of five measure-
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Single passive leg movement
The sPLM technique was used as an indicator of NO-dependent 
peripheral vascular function, according to standardized methods 
(40, 41). sPLM was always performed without H1/H2 blockade. Blood 
flow was determined on a beat-by-beat basis, smoothed by a five-beat 
average and peak blood flow; change from baseline to peak flow 
(∆ flow) and iAUC (trapezoidal method) were determined as standard 
parameters for vascular function. Blood flow was measured in the 
right femoral artery in both the acute and chronic study using Doppler 
Ultrasound (Xario 100; Canon Medical Systems Europe, Zoetermeer, 
The Netherlands). More details are in the Supplementary Materials.
Submaximal exercise test
After a 5-min warm-up at 75 W, participants cycled at 150 W for 
10 min. Whole-body oxygen uptake (breath by breath) and heart rate 
(continuous) were measured. In addition, a capillary blood sample 
was collected 1 min after the end of exercise and analyzed for lactate 
concentration (Biosen C-Line; EKF Diagnostics, Cardiff, UK). Breath- 
by-breath VO2 data were transformed into 10-s averages, and VO2 
and heart rate data of the last 8 min at 150 W were analyzed to 
ensure a metabolic steady state after the abrupt increase in work rate. 
Substrate oxidation (carbohydrate and fat) and total energy expen-
diture were calculated from the gas exchange data using stoichio-
metric equations (42).
Oral glucose tolerance test
After an overnight fast, an intravenous catheter was inserted and blood 
samples were obtained before and after (30, 60, 90, and 120 min) 
consumption of 75 g of glucose (dissolved in 300 ml of drinking 
water). The Matsuda insulin sensitivity index, a widely used method 
to assess whole-body insulin sensitivity, was calculated as described 
previously (43). More details are in the Supplementary Materials.
Muscle biopsies
After local anesthesia (0.5 ml of Xylocaïne, 1% without epinephrine; 
Aspen Netherlands B.V., Gorinchem, The Netherlands) and a small 
incision (3 mm), a biopsy was taken from the right m. vastus lateralis 
using the percutaneous Bergstrom needle biopsy technique with 
suction (44). One part of the muscle sample was immediately frozen 
in liquid nitrogen (enzyme activity, Western blot, and VEGF), 
whereas the other part was mounted in embedding medium (OCT 
Compound Tissue-Tek; Sakura Finetek, Zoeterwoude, The Nether-
lands), frozen in liquid nitrogen–cooled isopentane, and subsequently 
frozen in liquid nitrogen (histochemical analysis). All muscle samples 
were stored at −80°C until further analysis. Before analysis, non- 
embedded muscle samples were freeze-dried (48 hours); dissected 
free from blood, fat, and connective tissue; and divided into two 
pieces for Western blotting/VEGF (6 to 8 mg) and enzyme activities 
(2 to 3 mg).
Enzyme activity
Freeze-dried muscle samples (2 to 3 mg) were homogenized in 
phosphate/bovine serum albumin (BSA) buffer twice for 40 s at 
28.5 Hz (QIAGEN TissueLyser II; Retsch GmbH, Haan, Germany), 
and the total protein concentration was determined by a BSA stan-
dard kit (Pierce Reagents, Rockford, IL, USA). Maximal enzyme 
activity of CS, HAD, HK, PFK, and LDH was quantified on the 
homogenates using standard fluorometric methods (Fluoroskan 
Ascent; Thermo Fisher Scientific, Waltham, MA, USA) (45). Analysis 
was performed in triplicate (CS, HAD, HK, and PFK) or quadruplicate 
(LDH), averaged, and expressed relative to the total protein content.
Western blotting
Western blotting on muscle lysates was performed as described pre-
viously (46), with details in the Supplementary Materials.
Muscle VEGF
VEGF protein levels were determined in the muscle lysates as previ-
ously described (47) using a human VEGF kit according to the 
manufacturer’s instructions (catalog no. K151RHG-2, Human VEGF 
kit; Meso Scale Discovery, Rockville, MD, USA). Samples were ana-
lyzed in duplicate, measured with QuickPlex SQ 120 (catalog no. 
AI0AA-0, Meso Scale Discovery), and analyzed using Discovery 
Workbench Software. VEGF is expressed relative to total protein 
content in the muscle lysates.
Immunohistochemical analysis
Analysis of capillary-fiber ratio, capillary density, and mean cross- 
sectional fiber area was performed by immunohistochemistry as 
described previously (48). Details can be found in the Supplementary 
Materials.
Statistical analysis
Researchers analyzing the data were blinded to the condition of the 
participants. Data were analyzed with R (version 4.0.0) in the RStudio 
interface (version 1.2.5033) with two-sided statistical tests. Changes 
over time in the acute and chronic study were analyzed using a lin-
ear mixed model approach with the lme4 package. The model was 
checked for homogeneity of variance and normality of the residuals 
using residual plots/Levene’s tests and Q-Q plots/Shapiro-Wilk’s tests. 
In case of violations of these assumptions, data were log-transformed 
before analysis, followed by rechecking of the model. For the acute 
study, fixed factors were condition (control or blockade) and time 
(nine time points), and for the chronic study, fixed factors were 
group (placebo or blockade) and time (before, halfway, and after 
the intervention). Participants were always specified as random inter-
cept in the model. In case of significant main or interaction effects, 
analysis was followed by post hoc pairwise comparisons with Tukey 
adjustments for multiple comparisons (emmeans package). Differ-
ences in iAUC between conditions in the acute study were analyzed 
with paired t tests. For the chronic study, differences in changes from 
before to after the intervention between groups were analyzed with 
unpaired t tests. In case of non-normally distributed data (Shapiro- 
Wilk and Q-Q plots), a Wilcoxon signed-rank test was conducted 
instead of unpaired t tests. Relationships between variables were 
investigated with Pearson correlation coefficients, after verifying 
normality and log transform if necessary. For all analyses, statistical 
outliers were maintained in the dataset if physiologically plausible, 
although we conducted statistical analyses with and without the ex-
treme outliers. These analyses did not alter interpretation of the re-
sults, verifying validity of the results. The significance level was set 
at P < 0.05, and results are presented as means ± SD unless other-
wise noted.
SUPPLEMENTARY MATERIAL
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/7/16/eabf2856/DC1
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